Anti-VEGFR2 x Anti-VEGFR3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-VEGFR2 and anti-VEGFR3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two receptors simultaneously. It is designed for the research of Cancers therapy.
There are currently no customer reviews or questions for Anti-VEGFR2 x Anti-VEGFR3 Bispecific Antibody (IgG-IgG) (BSIG-191). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS